Duncan McKechnie
EVP, Chief Commercial Officer at Vertex Pharmaceuticals · 10 reported transactions in 1 company · latest trade Jul 2, 2026
Their trades
Sold | Jul 2, 2026 | Jul 2, 2026 close $528.04 → Oct 29, 2026 close $540.00. S&P 500 +3.3% over the same days. | ||
Sold | Feb 25, 2026 | Feb 25, 2026 close $483.05 → Oct 29, 2026 close $540.00. S&P 500 +11.0% over the same days. | ||
Sold | Feb 25, 2026 | Feb 25, 2026 close $483.05 → Oct 29, 2026 close $540.00. S&P 500 +11.0% over the same days. |
$799.8K
Jul 2, 2026 close $528.04 → Oct 29, 2026 close $540.00. S&P 500 +3.3% over the same days.
$1.18M
Feb 25, 2026 close $483.05 → Oct 29, 2026 close $540.00. S&P 500 +11.0% over the same days.
$1.22M
Feb 25, 2026 close $483.05 → Oct 29, 2026 close $540.00. S&P 500 +11.0% over the same days.